{
    "2020-04-28": [
        [
            {
                "time": "",
                "original_text": "康龙化成(03759-HK)首季多赚87.16%",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "首季",
                        "净利润",
                        "增长",
                        "87.16%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(03759)一季度归属股东净利润同比增长87.16%至1.02亿元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "一季度",
                        "净利润",
                        "同比增长",
                        "87.16%",
                        "1.02亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(03759.HK)一季度净利润增长87.16%至1.02亿元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "一季度",
                        "净利润",
                        "增长",
                        "87.16%",
                        "1.02亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "现金流充裕，泰格医药为何还选择“A+H”模式上市？",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "A+H模式",
                        "上市",
                        "现金流"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759.SZ)：一季度净升87.16%至1.02亿元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "一季度",
                        "净利",
                        "增长",
                        "87.16%",
                        "1.02亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成：一季度净利润同比增长87.16%",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "一季度",
                        "净利润",
                        "同比增长",
                        "87.16%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成升逾2% 创上市新高",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "股价上涨",
                        "2%",
                        "上市新高"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【民生医药|点评】康龙化成: 降负债提供弹性，更关注盈利提升和扩产能节奏",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "降负债",
                        "盈利提升",
                        "扩产能",
                        "民生医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}